Cargando…
N-acetylcysteine improves established monocrotaline-induced pulmonary hypertension in rats
BACKGROUND: The outcome of patients suffering from pulmonary arterial hypertension (PAH) are predominantly determined by the response of the right ventricle to the increase afterload secondary to high vascular pulmonary resistance. However, little is known about the effects of the current available...
Autores principales: | Chaumais, Marie-Camille, Ranchoux, Benoît, Montani, David, Dorfmüller, Peter, Tu, Ly, Lecerf, Florence, Raymond, Nicolas, Guignabert, Christophe, Price, Laura, Simonneau, Gérald, Cohen-Kaminsky, Sylvia, Humbert, Marc, Perros, Frédéric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065537/ https://www.ncbi.nlm.nih.gov/pubmed/24929652 http://dx.doi.org/10.1186/1465-9921-15-65 |
Ejemplares similares
-
The Beneficial Effect of Suramin on Monocrotaline-Induced Pulmonary Hypertension in Rats
por: Izikki, Mohamed, et al.
Publicado: (2013) -
Increased oxidative stress and severe arterial remodeling induced by permanent high-flow challenge in experimental pulmonary hypertension
por: Dorfmüller, Peter, et al.
Publicado: (2011) -
In vivo miR-138-5p inhibition alleviates monocrotaline-induced pulmonary hypertension and normalizes pulmonary KCNK3 and SLC45A3 expression
por: Le Ribeuz, Hélène, et al.
Publicado: (2020) -
Trichloroethylene increases pulmonary endothelial permeability: implication for pulmonary veno-occlusive disease
por: Caliez, Julien, et al.
Publicado: (2020) -
Chronic thromboembolic pulmonary hypertension complicating long-term cyproterone acetate therapy
por: Montani, David, et al.
Publicado: (2014)